Evidence for altered interleukin (IL)‐18 pathway in human heart failure
Open Access
- 15 September 2004
- journal article
- fj express-summarie
- Published by Wiley in The FASEB Journal
- Vol. 18 (14) , 1752-1754
- https://doi.org/10.1096/fj.04-2426fje
Abstract
Interleukin (IL)-18 is the interferon-γ-inducing factor and has potent proinflammatory activities. IL-18 has been recently implicated in atherosclerotic plaque instability and myocardial ischemia-rep...Keywords
Funding Information
- British Heart Foundation
This publication has 44 references indexed in Scilit:
- Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and MacrophagesThe Journal of Experimental Medicine, 2002
- Inhibition of Myocardial Apoptosis as a Therapeutic Target in Cardiovascular Disease PreventionHeart Disease, 2001
- IL-12–induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursorJournal of Clinical Investigation, 1999
- Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardiumJournal of Clinical Investigation, 1999
- Endotoxin and immune activation in chronic heart failure: a prospective cohort studyThe Lancet, 1999
- Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.Journal of Clinical Investigation, 1998
- Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting EnzymeScience, 1997
- Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.Journal of Clinical Investigation, 1996
- Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or HypertensionJournal of the American College of Cardiology, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996